WO2007049124A1 - Method of making 8-fluoro-naphthalen-1-ylamine and related compounds - Google Patents

Method of making 8-fluoro-naphthalen-1-ylamine and related compounds Download PDF

Info

Publication number
WO2007049124A1
WO2007049124A1 PCT/IB2006/002979 IB2006002979W WO2007049124A1 WO 2007049124 A1 WO2007049124 A1 WO 2007049124A1 IB 2006002979 W IB2006002979 W IB 2006002979W WO 2007049124 A1 WO2007049124 A1 WO 2007049124A1
Authority
WO
WIPO (PCT)
Prior art keywords
hydrogen fluoride
ylamine
fluoro
triazine
donor base
Prior art date
Application number
PCT/IB2006/002979
Other languages
French (fr)
Inventor
Zhijian Zhu
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of WO2007049124A1 publication Critical patent/WO2007049124A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/067Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/64Preparation of compounds containing amino groups bound to a carbon skeleton by disproportionation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/08Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems

Definitions

  • the present invention relates to methods of preparing 8-fluoro-naphthalen-l- ylamine, an 8-halo-naphthalen-l-ylamine, and to the use of such compounds as intermediates in the synthesis of 7- ⁇ 4-[4-(8-fluoro-napthalen-l-yl)-piperazin-l-yl]- butoxy ⁇ -3 ,4-dihydro- IH- [ 1 ,8]naphthyridin-2-one.
  • US Patent Application Publication 2005/0043309Al discloses a process for synthesis of 7- ⁇ 4-[4-(8-fluoro-napthalen-l-yl)-pi ⁇ erazin-l-yl]-butoxy ⁇ -3,4- dihydro-lH-[l,8]naphthyridin-2-one, a dopamine D 2 partial agonist indicated for use in the treatment of schizophrenia, in which l-(8-fluoro-naphthalen-l-yl)-piperazine is used as an intermediate.
  • the synthesis process used to make that particular intermediate is not suitable for making large quantities of the product due to its high cost and difficulties in controlling the operation.
  • Figure 1 illustrates several methods for making 8-fluoro-naphthalen-l-ylamine (1) disclosed in the literature.
  • Figure 1 illustrates the preparation of compound 1 from l-fluoro-8-nitronaphthalene (3) by iron reduction (Bull. Soc. Chim. BeIg, 1966, 75, 577-581).
  • Figure 1 also illustrates methods for making compound 1 from compound 4 disclosed in the literature.
  • compound 3 was prepared by nitration of 1-fluoronaphthalene (6) ⁇ Israel Journal of Chemistry, 1977, 16, 299-303). However, the nitration gave a mixture of l-fluoro-2-nitronaphthalene, l-fluoro-4-nitronaphthalene and 3, and the products were separated by column chromatography.
  • compound 3 was prepared from 8- nitro-1-naphthalylamine (5) through a Schiemann reaction (Bull. Soc. CMm. BeIg, 1966, 75, 577-581).
  • the nitration of 1-naphthylamine (8) gave only 38% yield of 5, together with the generation of 5-nitro- 1-naphthylamine (Journal of the Chemical Society, 1939, 348).
  • Compound 5 has also been prepared by mono-reduction of 1,8- dinitronaphthalene (7) (Collection of Czechoslovak Chemical Communications, 1929, 1, 360).
  • Compound 7 is both heat and shock sensitive, which limits its utility, particularly, in large scale preparations.
  • compound 1 could be prepared from 8-fluoro-l-naphthalenecarboxylic acid (2) through a Curtis or Hoffmann rearrangement reaction.
  • compound 2 could be prepared from ethyl (o-fluorophenyl)acetate (4) (Journal of Organic Chemistry, 2002, 67, 1171-1177).
  • German patent DE 147852 disclosed that lH-naphtho[l,8-de][l,2,3]triazine could be converted to 8-chloro-l-aminonaphthalene upon exposure to concentrated hydrochloric acid and hydrogen chloride gas in the presence of copper with heating.
  • the present invention relates to a method of preparing 8-flouro-napthalen-l- ylamine.
  • the method comprises reacting lH-naphtho[l,8-de][l,2,3]triazine with hydrogen fluoride or with a complex of hydrogen fluoride and an n-donor base.
  • the present invention further relates to a method of preparing l-(8-fluoro-napthalen-l-yl)-piperazine from 8-fluoro-naphthalen-l-ylamine.
  • alkyl as used herein, unless otherwise indicated, includes saturated monovalent hydrocarbon radicals having straight, branched or cyclic moieties or combinations thereof.
  • alkyl groups include, but are not limited to, methyl, ethyl, propyl, isopropyl, butyl, iso- sec- and tert-butyl, pentyl, hexyl, heptyl, 3-ethylbutyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, norbornyl, and the like.
  • alkoxy as used herein, unless otherwise indicated, means “alkyl-O- ", wherein “alkyl” is as defined above.
  • alkoxy groups include, but are not limited to, methoxy, ethoxy, propoxy, butoxy and pentoxy.
  • halo and halogen, as used herein, unless otherwise indicated, include, fluoro, chloro, bromo and iodo.
  • the present invention relates to a method of preparing 8- flouro-napthahlen-1-ylamine from lH-naphtho[l,8-de][l,2,3]triazine by reacting the triazine with hydrogen fluoride or with a complex of hydrogen fluoride and an n-donor base.
  • the n-donor base is selected from the group consisting of tetrahydrofuran, an amine, an amide, a carbamic acid, an ester, a trialkylphosphine, or an alcohol.
  • the n-donor base is more preferably a compound of formula 1:
  • R 1 is hydrogen, hydroxyl, amino, nitro, halo, C 1 -C 5 alkyl, or C 1 -C 5 alkoxy.
  • the compound of formula 1 is preferably pyridine.
  • lH-naphtho[l,8-de][l,2,3]triazine behaves like a stabilized diazonium compound, allowing the introduction of a fluoro group but with much reduced thermo instability.
  • the ratio of hydrogen fluoride to pyridine used in the complex is preferably from 70% hydrogen fluoride and 30% pyridine to 57% hydrogen fluoride and 43% pyridine, more preferably 70% hydrogen fluoride and 30% pyridine, (w/w, relative to the total weight of the complex)
  • lH-naphtho[l,8- de][l,2,3]triazine is reacted with hydrogen fluoride or a complex of hydrogen fluoride and an n-donor base as described above, it is preferably done at a temperature between -30 0 C to 150°C, more preferably at a temperature of about 5°C to 55°C, even more preferably at a temperature of about 2O 0 C to 3O 0 C.
  • the reaction of lH-naphtho[l,8-de][l,2,3]triazine with hydrogen fluoride or a complex of hydrogen fluoride and an n-donor base is carried out in the presence of a solvent.
  • the solvent is preferably selected from the group consisting of 2-methoxyethanol, tetrahydrofuran, 1,4-dioxane, 2-methyltetrahydofuran, 1,2- dimethoxyethane, diethyleneglycol dimethyl ether, toluene, chlorobenzene, dichlorobenzene, and dichloromethane, dichloroethane.
  • any one of a number of methods known in the art are suitable for use in making the lH-naphtho[l,8-de][l,2,3]triazine used in the present invention.
  • the IH- naphtho[l,8-de][l,2,3]triazine is preferably prepared from 1,8-diaminona ⁇ hthalene.
  • a suitable procedure for preparing lH-naphtho[l,8-de][l,2,3]triazine from 1,8- diaminonaphthalene is described in Journal of the Chemical Society, 1969, 756.
  • 1,8- Diaminonaphthalene is an inexpensive starting material for making 8-flouro-napthahlen-l- ylamine (via a lH-naphtho[l,8-de][l,2,3]triazine intermediate) compared to 8-bromo- naphthalene-1-carboxylic acid, the starting material in the process for making l-(8-fluoro- naphthalen-l-yl)piperazine disclosed in Example A66 of US2005/0043309A1. Furthermore, the synthesis of 8-fluoro-naphthalen-l-ylamine using the method of the present invention requires fewer synthesis steps, fewer purification steps, and milder reaction conditions than methods described in the literature.
  • the process of the present invention further comprises reacting the 8-fluoro-l-aminonaphthalene, produced as described above, with bis(2- chloroenthylamine hydrochloride to produce l-(8-fluoro-naphthalen-l-yl)piperizine.
  • a preferred embodiment of this process, starting with 1,8-diaminonaphthalene, is illustrated in the reaction scheme of Figure 2, below:
  • 1,8-diaminonaphthalene (25Og, 1.58 mole) was dissolved in a mixture of acetic acid (500 mL) and ethanol (2500 mL) under nitrogen at room temperature.
  • Isoamyl nitrite (208.1 mL, 1.55 mole, 0.98 eq) was then added dropwise over a period of 3.5 hours with the temperature of the reaction mixture maintained between 18 0 C and 21°C. After the addition, the resulting red suspension was stirred at room temperature for 19 hours.
  • the resulting mixture was diluted with ethyl acetate (“EtOAc”) (500 mL) and stirred for 20 minutes, and product isolated from the mixture through a series of separation steps.
  • the mixture was transferred to a 6-L separatory funnel through suction.
  • the aqueous layer was separated and removed.
  • the organic layer and emulsion interface were filtered through Celite ® (diatomaceous earth) to remove solid.
  • the filtering cake was washed with ethyl acetate (2 X 200 mL).
  • the bi-layer filtrate (now nicely separated) was separated.
  • the organic layer was washed twice with a mix of saturated sodium chloride (300 mL), water (300 mL) and saturated sodium bicarbonate (300 mL); then saturated sodium chloride (300 mL). The organic layer was then degassed by bubbling nitrogen for 20 minutes to remove oxygen and prevent oxidation. The solution was stirred under nitrogen with activated carbon (Sigma-Aldrich, 242276, Darco, G-60, 100 mesh, 50 g) for 5 hours, and additional activated carbon (50g) overnight. The activated carbon was removed by filtration through Celite ® , the solid cake was washed with EtOAc (2 x 300 mL).
  • activated carbon Sigma-Aldrich, 242276, Darco, G-60, 100 mesh, 50 g

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

A process is described for preparing 8-flouro-napthalen-l-ylamine comprising reacting lH-naphtlio[l,8-de][l,2,3]triazine with hydrogen fluoride or a complex of hydrogen fluoride and an n-donor base. A process is also set forth for using 8-fluoro- naphthalen-1-ylamine produced as described above in the preparation of l-(8-fluoro- napthalen-l-yl)-piperazine, which can be used as an intermediate in the production of 7- { 4- [4-(8-fluoro-napthalen- 1 -yl)-piperazin- 1 -yl] -butoxy } -3 ,4-dihydro- IH- [l,8]naphthyridin-2-one, a D2 partial agonist indicated for possible use in the treatment of schizophrenia.

Description

METHOD OF MAKING δ-FLUORO-NAPHTHALEN- 1 -YLAMINE AND RELATED
COMPOUNDS FIELD OF THE INVENTION
[0001] The present invention relates to methods of preparing 8-fluoro-naphthalen-l- ylamine, an 8-halo-naphthalen-l-ylamine, and to the use of such compounds as intermediates in the synthesis of 7-{4-[4-(8-fluoro-napthalen-l-yl)-piperazin-l-yl]- butoxy } -3 ,4-dihydro- IH- [ 1 ,8]naphthyridin-2-one.
BACKGROUND
[0002] US Patent Application Publication 2005/0043309Al (Example A66) discloses a process for synthesis of 7-{4-[4-(8-fluoro-napthalen-l-yl)-piρerazin-l-yl]-butoxy}-3,4- dihydro-lH-[l,8]naphthyridin-2-one, a dopamine D2 partial agonist indicated for use in the treatment of schizophrenia, in which l-(8-fluoro-naphthalen-l-yl)-piperazine is used as an intermediate. Unfortunately, the synthesis process used to make that particular intermediate is not suitable for making large quantities of the product due to its high cost and difficulties in controlling the operation. Specifically, in the first step of the process 8- bromo-naphthalene-1-carboxylic acid, a very expensive compound, was used to make 8- bromo-naphthalene-1-ylamine through a Curtis rearrangement reaction. The large amount of heat released in the process makes safe operation difficult. A Schiemann diazotization/fluoro-dediazotization reaction was used in the second step of the process to produce l-bromo-8-fluoro-naphthalene. The product of that reaction was then used to make the l-(8-fluoro-naphthalen-l-yl)-piperazine intermediate.
[0003] One could contemplate making l-(8-fluoro-naphthalen-l-yl)-piperazine from another 8-halo-naphthalen-l-ylamine intermediate, 8-fluoro-naphthalen-l-ylamine, by the formation of piperazine with the use of inexpensive compounds. However, methods for making that particular intermediate disclosed in the literature involve numerous steps, produce many impurities, or utilize labile compounds. Figure 1, below, illustrates several methods for making 8-fluoro-naphthalen-l-ylamine (1) disclosed in the literature. One such reference describes the preparation of compound 1 from l-fluoro-8-nitronaphthalene (3) by iron reduction (Bull. Soc. Chim. BeIg, 1966, 75, 577-581). Figure 1 also illustrates methods for making compound 1 from compound 4 disclosed in the literature. [0004] Figure 1
Figure imgf000003_0001
[0005] In one method illustrated in Figure 1, compound 3 was prepared by nitration of 1-fluoronaphthalene (6) {Israel Journal of Chemistry, 1977, 16, 299-303). However, the nitration gave a mixture of l-fluoro-2-nitronaphthalene, l-fluoro-4-nitronaphthalene and 3, and the products were separated by column chromatography.
[0006] In another method illustrated in Figure 1, compound 3 was prepared from 8- nitro-1-naphthalylamine (5) through a Schiemann reaction (Bull. Soc. CMm. BeIg, 1966, 75, 577-581). However, the nitration of 1-naphthylamine (8) gave only 38% yield of 5, together with the generation of 5-nitro- 1-naphthylamine (Journal of the Chemical Society, 1939, 348). Compound 5 has also been prepared by mono-reduction of 1,8- dinitronaphthalene (7) (Collection of Czechoslovak Chemical Communications, 1929, 1, 360). Compound 7 is both heat and shock sensitive, which limits its utility, particularly, in large scale preparations.
[0007] In another method illustrated in Figure 1, compound 1 could be prepared from 8-fluoro-l-naphthalenecarboxylic acid (2) through a Curtis or Hoffmann rearrangement reaction. However, one reference discloses that it took five synthesis steps to prepare compound 2 from ethyl (o-fluorophenyl)acetate (4) (Journal of Organic Chemistry, 2002, 67, 1171-1177).
[0008] As can be seen, none of the reaction schemes illustrated or described above are suitable for a practical, safe, and economic preparation of 8-fluoro-naphthalen-l-ylamine, a useful intermediate that could be used in the synthesis of compounds such as l-(8- fluoro-naphthalen- 1 -yl)-piperazine or 7- { 4- [4-(8-fluoro-napthalen- l-yl)-piperazin- 1 -yl]- butoxy } -3,4-dihydro- lH-[ 1 ,8]naphthyridin-2-one.
[0009] German patent DE 147852 disclosed that lH-naphtho[l,8-de][l,2,3]triazine could be converted to 8-chloro-l-aminonaphthalene upon exposure to concentrated hydrochloric acid and hydrogen chloride gas in the presence of copper with heating. However, one would not expect to be able to modify that process to displace the triazine with fluoride to make 8-fluoro-napthalen-l-ylamine, given the fact that fluoride is less nucleophilic than chloride.
BRIEF SUMMARY OF THE INVENTION
[0010] The present invention relates to a method of preparing 8-flouro-napthalen-l- ylamine. The method comprises reacting lH-naphtho[l,8-de][l,2,3]triazine with hydrogen fluoride or with a complex of hydrogen fluoride and an n-donor base. The present invention further relates to a method of preparing l-(8-fluoro-napthalen-l-yl)-piperazine from 8-fluoro-naphthalen-l-ylamine.
[0011] The term "alkyl", as used herein, unless otherwise indicated, includes saturated monovalent hydrocarbon radicals having straight, branched or cyclic moieties or combinations thereof. Examples of "alkyl" groups include, but are not limited to, methyl, ethyl, propyl, isopropyl, butyl, iso- sec- and tert-butyl, pentyl, hexyl, heptyl, 3-ethylbutyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, norbornyl, and the like.
[0012] The term "alkoxy", as used herein, unless otherwise indicated, means "alkyl-O- ", wherein "alkyl" is as defined above. Examples of "alkoxy" groups include, but are not limited to, methoxy, ethoxy, propoxy, butoxy and pentoxy.
[0013] The terms "halo" and "halogen", as used herein, unless otherwise indicated, include, fluoro, chloro, bromo and iodo.
DETAILED DESCRIPTION OF THE INVENTION
[0014] In one embodiment, the present invention relates to a method of preparing 8- flouro-napthahlen-1-ylamine from lH-naphtho[l,8-de][l,2,3]triazine by reacting the triazine with hydrogen fluoride or with a complex of hydrogen fluoride and an n-donor base. [0015] In another embodiment, the n-donor base is selected from the group consisting of tetrahydrofuran, an amine, an amide, a carbamic acid, an ester, a trialkylphosphine, or an alcohol. The n-donor base is more preferably a compound of formula 1:
Figure imgf000005_0001
wherein R1 is hydrogen, hydroxyl, amino, nitro, halo, C1-C5 alkyl, or C1-C5 alkoxy. The compound of formula 1 is preferably pyridine. For a discussion of methods of using hydrogen fluoride and complexes of hydrogen fluoride and n-donor bases as fluorinating reagents of other compounds see Journal of Organic Chemistry, 1979, 44, 3872 and references cited therein.
[0016] As illustrated in Example 2, below, the conversion of lH-naphtho[l,8- de][l,2,3]triazine to 8-flouro-napthahlen-l-ylamine according to the method of the present invention can be accomplished using a complex of hydrogen fluoride and pyridine under more mild reaction conditions than were used to convert the same triazine to 8-chloro- napthalen-1-ylamine as described in DE 147852. This is surprising because fluoride is less nucleophilic than chloride. Additionally, it appears that in the process of the present invention, lH-naphtho[l,8-de][l,2,3]triazine behaves like a stabilized diazonium compound, allowing the introduction of a fluoro group but with much reduced thermo instability. The differential scanning calorimetry ("DSC") analysis of lH-naphtho[l,8- de][l,2,3]triazine carried out as described in Example 1, below, showed an onset temperature of 24O0C with energy of 817J/g. This indicates that the compound has a much greater safety margin for handling than other diazonium compounds. Additionally, no column purification is required in order to complete the conversion from lH-naphtho[l,8- de][l,2,3]triazine to 8-flouro-napthahlen-l-ylamine.
[0017] When pyridine is used as the n-donor base in a hydrogen fluoride/n-donor base complex in the embodiment of the present method described above, the ratio of hydrogen fluoride to pyridine used in the complex is preferably from 70% hydrogen fluoride and 30% pyridine to 57% hydrogen fluoride and 43% pyridine, more preferably 70% hydrogen fluoride and 30% pyridine, (w/w, relative to the total weight of the complex) [0018] In another embodiment of the present invention, when lH-naphtho[l,8- de][l,2,3]triazine is reacted with hydrogen fluoride or a complex of hydrogen fluoride and an n-donor base as described above, it is preferably done at a temperature between -300C to 150°C, more preferably at a temperature of about 5°C to 55°C, even more preferably at a temperature of about 2O0C to 3O0C.
[0019] In another embodiment, the reaction of lH-naphtho[l,8-de][l,2,3]triazine with hydrogen fluoride or a complex of hydrogen fluoride and an n-donor base is carried out in the presence of a solvent. The solvent is preferably selected from the group consisting of 2-methoxyethanol, tetrahydrofuran, 1,4-dioxane, 2-methyltetrahydofuran, 1,2- dimethoxyethane, diethyleneglycol dimethyl ether, toluene, chlorobenzene, dichlorobenzene, and dichloromethane, dichloroethane.
[0020] Any one of a number of methods known in the art are suitable for use in making the lH-naphtho[l,8-de][l,2,3]triazine used in the present invention. The IH- naphtho[l,8-de][l,2,3]triazine is preferably prepared from 1,8-diaminonaρhthalene. A suitable procedure for preparing lH-naphtho[l,8-de][l,2,3]triazine from 1,8- diaminonaphthalene is described in Journal of the Chemical Society, 1969, 756. 1,8- Diaminonaphthalene is an inexpensive starting material for making 8-flouro-napthahlen-l- ylamine (via a lH-naphtho[l,8-de][l,2,3]triazine intermediate) compared to 8-bromo- naphthalene-1-carboxylic acid, the starting material in the process for making l-(8-fluoro- naphthalen-l-yl)piperazine disclosed in Example A66 of US2005/0043309A1. Furthermore, the synthesis of 8-fluoro-naphthalen-l-ylamine using the method of the present invention requires fewer synthesis steps, fewer purification steps, and milder reaction conditions than methods described in the literature.
[0021] In another embodiment, the process of the present invention further comprises reacting the 8-fluoro-l-aminonaphthalene, produced as described above, with bis(2- chloroenthylamine hydrochloride to produce l-(8-fluoro-naphthalen-l-yl)piperizine. A preferred embodiment of this process, starting with 1,8-diaminonaphthalene, is illustrated in the reaction scheme of Figure 2, below:
[0022] Figure 2
NH2 NH2
Figure imgf000007_0001
Figure imgf000007_0002
[0023] In the process of making 8-flouro-napthahlen-l-ylamine illustrated in Figure 1 8-flouro-napthahlen-l-ylamine is reacted with the bis(2-chloroenthyl)amine hydrochloride in the presence of tetrabutylammonium iodide. This last reaction step preferably takes place in a mixture of hexylalcohol and chlorobenzene at reflux, as shown in Figure 2. [0024] The present invention is further illustrated by the following examples. These examples are intended to be illustrative of the invention and should not be used to limit or restrict its scope. In the examples below, the term "room temperature" refers to a temperature of 20°C to 27°C.
EXAMPLES [0025] Example 1 - Preparation of lH-Naphtho[l,8-de][l,2,3]triazine
Figure imgf000007_0003
[0026] 1,8-diaminonaphthalene (25Og, 1.58 mole) was dissolved in a mixture of acetic acid (500 mL) and ethanol (2500 mL) under nitrogen at room temperature. Isoamyl nitrite (208.1 mL, 1.55 mole, 0.98 eq) was then added dropwise over a period of 3.5 hours with the temperature of the reaction mixture maintained between 180C and 21°C. After the addition, the resulting red suspension was stirred at room temperature for 19 hours. The solid was collected by filtration, washed with ethanol (2 x 500 mL) and dried under vacuum to give lH-naphtho[l,8-de][l,2,3]triazine as a red crystalline solid (235.86g, 88%). IH NMR (400 MHz, OMSO-D6) δ ppm 13.24 (s, IH), 7.24 (m, 2H), 7.11 (m, IH), 7.01 (d, J = 8.40 Hz, IH), 6.86 (dd, /= 5.37, 2.64 Hz, IH), 6.10 (d, / = 7.23 Hz, IH). CHN analysis: calc. for C10H7N3: C% 70.99, H% 4.17, N% 24.84; found: C% 70.62, H% 4.06, N% 24.46.
[0027] Example 2 - Preparation of 8-FIuoro-naphthalen-l-ylamine:
HF/pyridine
Figure imgf000008_0002
Figure imgf000008_0001
[0028] Hydrogen fluoride-pyridine (70% HF/30% pyridine, 400 niL) was placed in a container and cooled in an ice bath. lH-Naphtho[l,8-de][l,2,3]triazine (100 g, 0.59 mole) was added slowly. After the addition, the container was rinsed with additional 100 g of hydrogen fluoride-pyridine to wash down the solid on the sidewall of the container. The container was sealed and connected to a nitrogen line. The solution was stirred under nitrogen at room temperature for 7 days. High pressure liquid chromatography ("HPLC") analysis showed all starting material had disappeared by the end of that period, with 94% product purity. The reaction was cooled in ice bath. Once the temperature was below 10°C, potassium hydroxide ("KOH") (45w%, 1.35 L) was slowly added with temperature maintained below 35°C. The final pH was about 11.
[0029] The resulting mixture was diluted with ethyl acetate ("EtOAc") (500 mL) and stirred for 20 minutes, and product isolated from the mixture through a series of separation steps. The mixture was transferred to a 6-L separatory funnel through suction. The aqueous layer was separated and removed. The organic layer and emulsion interface were filtered through Celite® (diatomaceous earth) to remove solid. The filtering cake was washed with ethyl acetate (2 X 200 mL). The bi-layer filtrate (now nicely separated) was separated. The organic layer was washed twice with a mix of saturated sodium chloride (300 mL), water (300 mL) and saturated sodium bicarbonate (300 mL); then saturated sodium chloride (300 mL). The organic layer was then degassed by bubbling nitrogen for 20 minutes to remove oxygen and prevent oxidation. The solution was stirred under nitrogen with activated carbon (Sigma-Aldrich, 242276, Darco, G-60, 100 mesh, 50 g) for 5 hours, and additional activated carbon (50g) overnight. The activated carbon was removed by filtration through Celite®, the solid cake was washed with EtOAc (2 x 300 mL). The filtrate (red-wine color) was concentrated to give an oil, which was azeotroped with chlorobenzene twice (2 x 500 mL). The oil was solidified after sitting at room temperature overnight. The solid was further dried under vacuum to give 8-fluoro- naρhthalen-1-ylamine as a red-brown solid (86.1g, 90.4%). IH NMR (400 MHz, DMSO- D6) δ ppm 7.48 (dd, J = 8Hz, IH), 7.27 (m, IH), 7.19 (t, IH), 7.03 (m, 2H), 6.65 (dd, J = 8Hz, IH), 5.66 (s, 2H). CHN Analysis: calc. for C10H8FN: C% 74.52, H% 5.00, N% 8.69; Found: C% 74.36, H% 4.92, N% 8.79.
[0030] Example 3 - Preparation of l-(8-Fluoro-naphthalen-l-yl)piperazine Hydrochloride
Bis(chloroethyl)amine HCI Bu4NI (0.5eq), hexyl alcohol chlorobenzene, reflux
Figure imgf000009_0002
Figure imgf000009_0001
[0031] 8-Flouro-napthahlen-l-ylamine (168.86 g, 1.048 mole) was mixed with bis(2- chloroethyl)amine hydrochloride (Aldrich, B38503, 202.O g, 1.13 mol, 1.08 eq), tetrabutylammonium iodide (Aldrich, 140775, 193.5 g, 0.524 mmol, 0.5 eq) and hexyl alcohol (Aldrich, 100 mL) in anhydrous chlorobenzene (Aldrich, 1950 mL). The mixture was degassed by bubbling nitrogen for 20 minutes. The mixture was then heated to reflux under nitrogen for 74 hours to give a light brown suspension. The progress of the reaction was checked by HPLC. The suspension was slowly cooled to room temperature with gentle stirring overnight to give a nice brown suspension.
[0032] The solid was collected by filtration, washed with chlorobenzene (300 mL), toluene (300 mL), dried under vacuum at room temperature for 24 hours to give a yellow solid. The crude product was slurried in CH3CN (2x500mL) at room temperature for 4 to 5 hours. The solid was collected by filtration, dried under vacuum at room temperature to give l-(8-fluoro-naphthalen-l-yl)piperazine hydrochloride as a yellow solid (213.52 g, 76.4%). IH NMR (400 MHz, DMSO-D6) δ ppm 9.34 (bs, 2H), 7.70 (dd, J = 8Hz, IH), 7.62 (m, IH), 7.43 (m, 2H), 7.22 (m, IH), 7.10 (dd, J = 8Hz, IH), 3.33 (m, 4H), 3.11 (m, 2H), 3.00 (m, 2H). HPLC: 96.4% purity (Tr = 10.28 minutes, wavelength at 215 nm; YMC PackPre C 18, 150 X 4.6 mm, 3 μm; Solvent A: 0.2% HC1O4 in 90:10 water: ACN, Solvent B: ACN; Gradient: 90% A to 5% A in 30 minutes, then hold for 5 minutes; flow rate: l.O mL/min). Elemental Analysis: calc. for Cj4H15FN2 + 1.05HC1 + 0.6H2O: C% 60.19, H% 6.22, H% 10.03, Cl% 13.32; Found: C% 59.95, H% 6.09, N% 10.16, Cl% 13.62.

Claims

CLAIMSWhat is claimed is:
1. A method of preparing 8-flouro-napthalen- 1 -ylamine, comprising reacting lH-naphtho[l,8-de][l,2,3]triazine with hydrogen fluoride or a complex of hydrogen fluoride and an n-donor base to produce the 8-flouro-napthalen- 1 -ylamine.
2. The method of claim 1, wherein the n-donor base is selected from the group consisting of substituted tetrahydrofuran, amine, amide, carbamic acid, ester, trialkylphosphine, and alcohol.
3. The method of claim 2, wherein the n-donor base is a compound of formula 1:
Figure imgf000011_0001
wherein R1 is hydrogen, hydroxyl, amino, nitro, halo, C1-C5 alkyl, or C1-C5 alkoxy.
4. The method of claim 3, wherein the n-donor base is pyridine.
5. The method of claim 4 wherein the complex of hydrogen fluoride and pyridine has about 70% hydrogen fluoride (w/w) and 30% pyridine(w/w)
6. The method of claim 1, wherein the reaction of lH-naphtho[l,8-de][l,2,3]triazine with hydrogen fluoride or complex of hydrogen fluoride and an n-donor base is conducted at a temperature between -3O0C and 150°C.
7. The method of claim 6 , wherein the reaction of lH-naphtho[l,8-de][l,2,3]triazine with hydrogen fluoride or complex of hydrogen fluoride and an n-donor base is conducted at a temperature between 2O0C and 3O0C.
8. The method of claim 1, wherein the reaction of lH-naphtho[l,8-de][l,2,3]triazine with hydrogen fluoride or complex of hydrogen fluoride and an n-donor base is carried out in the presence of a solvent.
9. The method of claim 8, wherein the solvent is selected from the group consisting of 2-methoxyethanol, tetrahydrofuran, 1,4-dioxane, 2-methyltetrahydofuran, 1,2- dimethoxyethane, diethyleneglycol dimethyl ether, toluene, chlorobenzene, dichlorobenzene, dichloromethane, and dichloroethane.
10. A method of preparing l-(8-fluoro-naphthalen-l-yl)-piperazine, comprising: a) preparing 8-flouro-napthalen-l-ylamine according to the method of claim
I, and b) reacting the 8-flouro-napthahlen-l-ylamine with bis(2-chloroenthyl)amine hydrochloride.
II. The method of claim 10, wherein the 8-flouro-napthahlen-l-ylamine is reacted with the bis(2-chloroenthyl)amine hydrochloride in the presence of tetrabutylammonium iodide.
PCT/IB2006/002979 2005-10-24 2006-10-13 Method of making 8-fluoro-naphthalen-1-ylamine and related compounds WO2007049124A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72953005P 2005-10-24 2005-10-24
US60/729,530 2005-10-24

Publications (1)

Publication Number Publication Date
WO2007049124A1 true WO2007049124A1 (en) 2007-05-03

Family

ID=37885854

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2006/002979 WO2007049124A1 (en) 2005-10-24 2006-10-13 Method of making 8-fluoro-naphthalen-1-ylamine and related compounds

Country Status (4)

Country Link
JP (1) JP2007119461A (en)
AR (1) AR056154A1 (en)
TW (1) TW200800890A (en)
WO (1) WO2007049124A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023007515A (en) * 2019-12-10 2023-01-19 国立大学法人京都大学 Luminescent material, organic luminescent element and compound

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE147852C (en) *

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE147852C (en) *

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BULLETIN DES SOCIETES CHIMIQUES BELGES , 75(9-10), 577-81 CODEN: BSCBAG; ISSN: 0037-9646, 1966 *
DATABASE CAPLUS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; BASSILIOS, HELMY F. ET AL: ".alpha.-Fluoronitronaphthalenes and .alpha.-fluoronaphthylamines", XP002427278, retrieved from STN Database accession no. 1967:46238 *

Also Published As

Publication number Publication date
AR056154A1 (en) 2007-09-19
TW200800890A (en) 2008-01-01
JP2007119461A (en) 2007-05-17

Similar Documents

Publication Publication Date Title
JP6061158B2 (en) Synthesis intermediate of 6- (7-((1-aminocyclopropyl) methoxy) -6-methoxyquinolin-4-yloxy) -N-methyl-1-naphthamide, or a pharmaceutically acceptable salt thereof, and its use
CN107074738B (en) Process for preparing 2-substituted-1, 4-phenylenediamines and salts thereof
KR100892909B1 (en) Method for the continuous production of silicon compounds carrying amino groups
CN114195711B (en) Preparation method of quinoline-4 (1H) -ketone compound
JP4231479B2 (en) Process for producing 9- [4-acetoxy-3- (acetoxymethyl) but-1-yl] -2-aminopurine
US6794526B2 (en) Process for the preparation of manganese complexes of salen compounds
CN111233866B (en) Process for the preparation of tofacitinib or a salt thereof
WO2007049124A1 (en) Method of making 8-fluoro-naphthalen-1-ylamine and related compounds
JP4162274B2 (en) Process for producing bis (2-hydroxyphenyl-3-benzotriazole) methanes
JPH0458468B2 (en)
JP4157766B2 (en) Process for producing substituted imidazopyridine compounds
EP3990433A1 (en) Processes of making 2-((1-benzyl-1h-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives
RU2571417C2 (en) Method of producing n-substituted 2-amino-4-(hydroxymethylphosphenyl)-2-butenoic acid
JP3448635B2 (en) Sulfenamide compound and method for producing the same
EP1007517B1 (en) Process for the preparation of 5-hydroxymethylthiazoles
CN111100112A (en) Benzothiophene derivative and process for producing the same
CN113444023B (en) Synthesis method and application of tert-butoxycarbonyl protected ammonia compound
US12122751B2 (en) Processes of making 2-((1-benzyl-1H-indazol-3-yl)methoxy)-2-methylpropanoic acid and its derivatives
KR102638538B1 (en) New process for preparing intermediate of urapidil
JP4667589B2 (en) Method for producing 2,4-dihydroxypyridine
EP0535613B1 (en) Imine compounds and their production
CA2161046A1 (en) Process for large-scale production of bms 180048 and analogs
JP4507390B2 (en) 1-alkyl-1-substituted-3-organosulfonyloxyazetidinium salts and process for producing the same
CN114315773A (en) Piperazine compound and preparation method thereof
KR0129007B1 (en) 4-chloro-2-fluoru-5-(pentyl oxycarbonyl-methyloxy)nitrobenazene and the process of production thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06809116

Country of ref document: EP

Kind code of ref document: A1